BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15543299)

  • 1. Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragment.
    Corre C; Landreau CA; Shipman M; Lowden PA
    Chem Commun (Camb); 2004 Nov; (22):2600-1. PubMed ID: 15543299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of 3-methoxy-5-methyl naphthoic acid and its incorporation into the antitumor antibiotic azinomycin B.
    Ding W; Deng W; Tang M; Zhang Q; Tang G; Bi Y; Liu W
    Mol Biosyst; 2010 Jun; 6(6):1071-81. PubMed ID: 20485749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the azinomycin B biosynthetic gene cluster revealing a different iterative type I polyketide synthase for naphthoate biosynthesis.
    Zhao Q; He Q; Ding W; Tang M; Kang Q; Yu Y; Deng W; Zhang Q; Fang J; Tang G; Liu W
    Chem Biol; 2008 Jul; 15(7):693-705. PubMed ID: 18635006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azinomycins A and B, new antitumor antibiotics. I. Producing organism, fermentation, isolation, and characterization.
    Nagaoka K; Matsumoto M; Oono J; Yokoi K; Ishizeki S; Nakashima T
    J Antibiot (Tokyo); 1986 Nov; 39(11):1527-32. PubMed ID: 3793621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the molecular origin of the azinomycin epoxide: timing of the biosynthesis revealed.
    Sharma V; Kelly GT; Watanabe CM
    Org Lett; 2008 Nov; 10(21):4815-8. PubMed ID: 18841989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic manipulation of antibiotic-producing Streptomyces.
    Baltz RH
    Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro biosynthesis of the antitumor agent azinomycin B.
    Liu C; Kelly GT; Watanabe CM
    Org Lett; 2006 Mar; 8(6):1065-8. PubMed ID: 16524269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoacetone as the penultimate precursor to the antitumor agent azinomycin A.
    Sharma V; Kelly GT; Foulke-Abel J; Watanabe CM
    Org Lett; 2009 Sep; 11(17):4006-9. PubMed ID: 19663419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Role of N-Acetyl-glutamyl 5-Phosphate, an Acyl Phosphate, in the Construction of the Azabicycle Moiety of the Azinomycins.
    Nepal KK; Lee RP; Rezenom YH; Watanabe CM
    Biochemistry; 2015 Jul; 54(29):4415-8. PubMed ID: 26161634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of AziR, a resistance protein of the DNA cross-linking agent azinomycin B.
    Foulke-Abel J; Kelly GT; Zhang H; Watanabe CM
    Mol Biosyst; 2011 Sep; 7(9):2563-70. PubMed ID: 21776524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first biosynthetic studies of the azinomycins: acetate incorporation into azinomycin B.
    Corre C; Lowden PA
    Chem Commun (Camb); 2004 Apr; (8):990-1. PubMed ID: 15069509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive products from Streptomyces.
    Bĕhal V
    Adv Appl Microbiol; 2000; 47():113-56. PubMed ID: 12876796
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential role of an unknown gene aziU3 in the production of antitumor antibiotic azinomycin B verified by utilizing optimized genetic manipulation systems for Streptomyces sahachiroi.
    Wang S; Zhao R; Liu K; Zhu M; Li A; He J
    FEMS Microbiol Lett; 2012 Dec; 337(2):147-54. PubMed ID: 23039858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a DNA-crosslinking azinomycin analogue.
    Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
    Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of azinomycin B: definition of regioselectivity and sequence selectivity of DNA cross-link formation and clarification of the role of the naphthoate.
    Coleman RS; Perez RJ; Burk CH; Navarro A
    J Am Chem Soc; 2002 Nov; 124(44):13008-17. PubMed ID: 12405827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-mycaminose biosynthetic pathway revised and conversion of desosamine pathway to mycaminose pathway with one gene.
    Melançon CE; Yu WL; Liu HW
    J Am Chem Soc; 2005 Sep; 127(35):12240-1. PubMed ID: 16131199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for culturing Streptomyces sahachiroi: biosynthetic origin of the enol fragment of azinomycin B.
    Kelly GT; Sharma V; Watanabe CM
    Bioorg Chem; 2008 Feb; 36(1):4-15. PubMed ID: 17904193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold.
    Alcaro S; Ortuso F; Coleman RS
    J Chem Inf Model; 2005; 45(3):602-9. PubMed ID: 15921450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating noncovalent interactions between the azinomycins and double-stranded DNA: importance of the naphthalene substitution pattern on interstrand cross-linking efficiency.
    Landreau CA; LePla RC; Shipman M; Slawin AM; Hartley JA
    Org Lett; 2004 Sep; 6(20):3505-7. PubMed ID: 15387534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.